Refine your search

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

A Phase 1/2 Study of Lenvatinib in combination with Everolimus in Recurrent and Refractory Pediatric Solid Tumors, including CNS tumors

A study of the safety of levatinib with everolimus for children with solid tumors and central nervous system tumors that returned or did not respond to previous treatment.
Suzanne Treadway at streadway@pennstatehealth@psu.edu or 717-531-3097
All
All
This study is NOT accepting healthy volunteers
NCT03245151
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
You have Ewing sarcoma/pPNET or Rhabdomyosarcoma or a HGG that has come back or is not responding to treatment
Your cancer can be measured by certain criteria
You are ≥2 years and ≤21 years of age
Exclusion Criteria:
You have lymphoma
You have a wound or injury that won't heal
Cancer
  Email this study information to me
  Contact the study team
  See more information
  Show all 1 locations

Study Locations

Hide all locations
Location
Hershey, PA